Cerebral venous thrombosis (CVT) is an unusual form of stroke. It is little researched largely because it accounts for less than 1% of all strokes. The study will provide a much better understanding for the reasons underlying CVT, which is an unusual but very important cause of stroke in young (mainly female) adults. It could lead to a better prediction of who will have a CVT, as well as to discovery of specific treatments.
Most stroke and transient ischaemic attack (TIA) survivors are asked to take medicines, which some can find difficult. However, taking the medicines prescribed after a stroke, or TIA, and following lifestyle advice can reduce the chance of another stroke by 80%. Unfortunately, over 25% of stroke survivors do not continue these medicines, even for the first year after their stroke. Another 20% take less than is needed for the medicines to work.
This research will use the views of stroke and TIA survivors to design a life-long medicines support service which could be provided by pharmacists.
Postgraduate Fellowship: Ms Emma Pilkington (TSA PGF 2015-02)
TSA LECT 2015/02 - Dr Nele Demeyere, University of Oxford
Fellow: Dr Holly Robson